An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs ...

Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

Nucleoside reverse transcriptase inhibitors -- antiretroviral drugs approved to treat HIV and hepatitis B -- were associated ...

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to ...

University of Virginia (UVA) scientists are set to pursue randomised clinical trials to examine the potential for a class of ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

The Centers for Disease Control and Prevention (CDC) and seven US pediatric medical centers report a notable association ...

Scientists are calling for clinical trials to test the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

While investigating how the medicine uses the body’s immune system to ward off HIV symptoms, researchers realized that it ...